GLPBio

Signaling Pathways

Research Area, Signaling Pathways | GlpBio Life Science Products Suppliers

Read More about this category

The antibody-drug conjugate (ADC), a humanized or human monoclonal antibody conjugated with highly cytotoxic small molecules (payloads) through chemical linkers, is a novel therapeutic format and has great potential to make a paradigm shift in cancer chemotherapy. The three components of the ADC together give rise to a powerful oncolytic agent capable of delivering normally intolerable cytotoxins directly to cancer cells, which then internalize and release the cell-destroying drugs. At present, two ADCs, Adcetris and Kadcyla, have received regulatory approval with >40 others in clinical development.

ADCs are administered intravenously in order to prevent the mAb from being destroyed by gastric acids and proteolytic enzymes. The mAb component of the ADC enables it to circulate in the bloodstream until it finds and binds to tumor-specific cell surface antigens present on target cancer cells. Linker chemistry is an important determinant of the safety, specificity, potency and activity of ADCs. Linkers are designed to be stable in the blood stream (to conform to the increased circulation time of mAbs) and labile at the cancer site to allow rapid release of the cytotoxic drug. First generation ADCs made use of early cytotoxins such as the anthracycline, doxorubicin or the anti-metabolite/antifolate agent, methotrexate. Current cytotoxins have far greater potency and can be divided into three main groups: auristatins, maytansines and calicheamicins.

The development of site-specific conjugation methodologies for constructing homogeneous ADCs is an especially promising path to improving ADC design, which will open the way for novel cancer therapeutics.

References:

[1] Tsuchikama K, et al. Protein Cell. 2016 Oct 14. DOI:10.1007/s13238-016-0323-0.

[2] Peters C, et al. Biosci Rep. 2015 Jun 12;35(4). pii: e00225. doi: 10.1042/BSR20150089.

Research Areas

Products Related to Signaling Pathways(40698)

  • GC80995 structure
    GC80995CRBN ligand-704
    CAS: 2446913-97-7
    Purity: >98.00%

    CRBN ligand-704 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80996 structure
    GC80996CRBN ligand-206
    CAS: 1486115-10-9
    Purity: >98.00%

    CRBN ligand-206 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80997 structure
    GC80997CRBN ligand-222
    CAS: 594862-53-0
    Purity: >98.00%

    CRBN ligand-222 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC80998 structure
    GC80998CRBN ligand-902
    CAS: 2913408-82-7
    Purity: >98.00%

    CRBN ligand-902 is a CRBN E3 ligase ligand that can be used for synthesis of PROTAC CDK2/4 Degrader-1 [1] .

  • GC80999 structure
    GC80999(R)-Desamino lenalidomide-5-Br
    CAS: 2243825-20-7
    Purity: >99.50%

    (R)-Desamino lenalidomide-5-Br is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81000 structure
    GC81000CRBN ligand-607
    CAS: 2925072-28-0
    Purity: >98.00%

    CRBN ligand-607 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81001 structure
    GC81001CRBN ligand-547
    CAS: 2446913-88-6
    Purity: >99.50%

    CRBN ligand-547 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81002 structure
    GC81002CRBN ligand-619
    CAS: 2229724-66-5
    Purity: >98.00%

    CRBN ligand-619 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81003 structure
    GC81003CRBN ligand-707
    CAS: 2925095-42-5
    Purity: >99.50%

    CRBN ligand-707 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81004 structure
    GC81004CRBN ligand-708
    CAS: 2925094-42-2
    Purity: >97.50%

    CRBN ligand-708 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81005 structure
    GC81005Desamino lenalidomide-6-Br-5-F
    CAS: 2438240-74-3
    Purity: >98.00%

    Desamino lenalidomide-6-Br-5-F is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81006 structure
    GC81006CRBN ligand-749
    CAS: 2760849-95-2
    Purity: >98.00%

    CRBN ligand-749 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81007 structure
    GC810075-Br-6-F-Desamino lenalidomide
    CAS: 2409005-96-3
    Purity: >98.00%

    5-Br-6-F-Desamino lenalidomide is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81008 structure
    GC81008CRBN ligand-733
    CAS: 2903425-10-3
    Purity: >98.00%

    CRBN ligand-733 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81009 structure
    GC81009CRBN ligand-896
    CAS: 2504234-93-7
    Purity: >98.00%

    CRBN ligand-896 (CRBN-1) is a E3 ligase ligand of PROTAC that can be used to synthesize PROTAC degraders targeting the epigenetic coactivator p300 [1] .

  • GC81010 structure
    GC81010CRBN ligand-774
    CAS: 2888604-15-5
    Purity: >98.00%

    CRBN ligand-774 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81011 structure
    GC81011Desamino lenalidomide-6-I
    CAS: 2757572-60-2
    Purity: >95.00%

    Desamino lenalidomide-6-I is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81012 structure
    GC81012Desamino lenalidomide-pinacolborane
    CAS: 2291363-98-7
    Purity: >98.00%

    Desamino lenalidomide-pinacolborane is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81013 structure
    GC81013CRBN ligand-838
    CAS: 2654822-43-0
    Purity: >98.00%

    CRBN ligand-838 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81014 structure
    GC81014CRBN ligand-734
    CAS: 2654830-24-5
    Purity: >98.00%

    CRBN ligand-734 is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81015 structure
    GC81015(S,R,S)-AHPC-Me-NHBoc
    CAS: 1997302-16-5
    Purity: >99.50%

    (S,R,S)-AHPC-Me-NHBoc is an E3 ubiquitin ligase VHL ligand used to recruit the VHL protein.

  • GC81016 structure
    GC81016Thalidomide-O-amido-PEG2-Mal
    Purity: >97.50%

    Thalidomide-O-amido-PEG2-Mal is an E3 ubiquitin ligase cereblon (CRBN) ligand used to recruit the cereblon protein.

  • GC81017 structure
    GC81017DCAF1 ligand 2
    Purity: >99.50%

    DCAF1 ligand 2 (Tert-butyl (2-((2-(1-(4-chlorophenyl)cyclohexyl)-7-(piperazin-1-yl)quinazolin-4-yl)amino)ethyl)carbamate) is a ligand of the E3 connecting enzyme DCAF1.

  • GC81018 structure
    GC81018(S,R,S)-AHPC-Me-C8-NHS ester
    Purity: >99.50%

    The (S,R,S)-AHPC-Me-C8-NHS ester is an E3 ubiquitin ligase VHL ligand, used to recruit the VHL protein.